GDF15 and obesity due to melanocortin 4 receptor deficiency: Additional prospective studies are required to validate the clinical use of GDF-15 in quantifying the relationship between obesity, heart failure, and subclinical atherosclerosis, as well as to assess its significance in individualized risk estimation and disease prevention.